Zucara Therapeutics Inc. — Form D

Zucara Therapeutics Inc. of TORONTO, A6, a company, filed a Form D exempt-offering notice with the SEC on 2025-03-06. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2025-03-06
• Form: D
• Accession: 0002059295-25-000002
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $5.0M
• Amount sold: $5.0M
• Investors: 3
• Date of first sale: 2025-02-03
• Security types: equity
• Revenue range: $1 - $1,000,000
• SEC file number: 021-540044

Issuer

• Name: Zucara Therapeutics Inc.
• CIK: 0002059295
• Entity type: Corporation
• Jurisdiction: CANADA (FEDERAL LEVEL)
• Address: 1300-661 UNIVERSITY AVENUE, TORONTO, A6, M5G 0B7
• Phone: 4168593978

Officers, directors & promoters (8)

More

• CIK 2059295 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search